McKesson and CD&R Agree to Buy Option Care in $5.8 Billion Deal
McKesson and private equity firm Clayton, Dubilier & Rice have agreed to acquire Option Care Health in a transaction valued at about $5.8 billion, taking the U.S. at-home infusion therapy provider private. The deal underscores continued investor appetite for healthcare services businesses with recurring demand, stable cash flows and exposure to shifting care delivery away from hospitals.
